A Phase III study of Fludarabine and Busulfan versus Fludarabine, Busulfan and low dose total body irradiation in patients receiving an allogeneic hematopoietic stem cell transplant

Sponsor
Hackensack UMC

Protocol Number
Hackensack UMC 00001278

To Learn More Call
201-510-0910